Download presentation
Presentation is loading. Please wait.
Published byJasper Warren Modified over 5 years ago
1
A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib Parneet K. Cheema, MD, MBiotech, FRCPC Journal of Thoracic Oncology Volume 12, Issue 12, Pages e200-e202 (December 2017) DOI: /j.jtho Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
2
Figure 1 (A and B) Computerized tomography at baseline before the start of afatinib therapy. (C and D) At week 12 after afatinib therapy. (D and E) At week 26 after afatinib therapy. Journal of Thoracic Oncology , e200-e202DOI: ( /j.jtho ) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.